Literature DB >> 17229073

The interleukin-12 family: new players in transplantation immunity?

S Goriely1, M Goldman.   

Abstract

Since several years ago, interleukin (IL)-12 is known to be responsible for the differentiation of naive CD4+ T cells into type 1 helper T cells producing interferon-gamma. Recently, two other cytokines of the IL-12 family, IL-23 and IL-27, were shown to play key roles in experimental autoimmune disorders mediated by Th17 cells, a novel pro-inflammatory CD4+ T-cell subset secreting IL-17. As our knowledge of IL-12 family members is rapidly growing and changing, it will be important to specify their involvement in the induction and regulation of allograft rejection in animal models as well as in clinical settings. Herein, we review key features of cytokines belonging to the IL-12 family and discuss their potential relevance to transplantation immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229073     DOI: 10.1111/j.1600-6143.2006.01651.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  15 in total

Review 1.  Novel immune regulatory pathways and their role in immune reconstitution syndrome in organ transplant recipients with invasive mycoses.

Authors:  N Singh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-23       Impact factor: 3.267

Review 2.  Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

Authors:  Lili Magyari; Dalma Varszegi; Erzsebet Kovesdi; Patricia Sarlos; Bernadett Farago; Andras Javorhazy; Katalin Sumegi; Zsolt Banfai; Bela Melegh
Journal:  World J Orthop       Date:  2014-09-18

3.  Involvement of indirectly allostimulated CD4+CD43highCD45RO+ T cell proliferation in the development of chronic allograft nephropathy.

Authors:  Yu-Mee Wee; Joo-Hee Jung; Yang-Hee Kim; Monica-Y Choi; Young-Hoon Kim; Do-Sook Choi; Myung-Hwan Cho; Duck-Jong Han
Journal:  Exp Biol Med (Maywood)       Date:  2015-09-07

Review 4.  Interleukin-23: as a drug target for autoimmune inflammatory diseases.

Authors:  Chunlei Tang; Shu Chen; Hai Qian; Wenlong Huang
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

5.  Dendritic cell differentiation with prostaglandin E results in selective attenuation of the extracellular signal-related kinase pathway and decreased interleukin-23 production.

Authors:  Fumie Hayashi; Yoshiki Yanagawa; Kazunori Onoé; Kazuya Iwabuchi
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

6.  Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2.

Authors:  Rong L He; Jian Zhou; Crystal Z Hanson; Jia Chen; Ni Cheng; Richard D Ye
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

7.  The value of serum neopterin, interferon-gamma levels and interleukin-12B polymorphisms in predicting acute renal allograft rejection.

Authors:  G K Chin; C L Adams; B S Carey; S Shaw; W-Y Tse; E R Kaminski
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

8.  IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17.

Authors:  Curtis J Henry; David A Ornelles; Latoya M Mitchell; Kristina L Brzoza-Lewis; Elizabeth M Hiltbold
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

9.  Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice.

Authors:  Guomin Jiang; Yan Ke; Deming Sun; Gencheng Han; Henry J Kaplan; Hui Shao
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

10.  Combination use of immune complexes and a Ca2(+) channel blocker azelnidipine enhances interleukin-12 p40 secretion without T helper type 17 cytokine secretion in human monocyte-derived dendritic cells.

Authors:  T Abe; I Fuse; M Narita; M Takahashi; Y Aizawa
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.